For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope. Exciting new research presented at the American Society of Clinical Oncology (ASCO) 2025 conference is ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with ...

Scientists, medical researchers at Case Western Reserve, NYU Langone Health and University Hospitals using machine-learning to predict response to immunotherapy Medical researchers from Case Western ...

MSK experts discuss FLAURA2 updates, emerging targets in mesothelioma, and next-gen immunotherapies from the 2026 European ...

Cancer survival might depend on what time of day you get your treatment, a new study says. Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures. Immunotherapy is changing treatment ...

In a cohort study of patients with advanced non-small cell lung cancer (NSCLC), exposure to certain antibiotics, high-dose steroids, or proton pump inhibitors (PPIs) at the start of immunotherapy was ...

Personalized cancer vaccines enhance immunotherapy by training T cells to recognize tumor-specific mutations, improving immune response against cancer cells. Dr. Thomas Marron emphasizes the ...

Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to ...

Neoadjuvant or perioperative immunotherapy, either alone or in combination with other antineoplastic agents (e.g., chemotherapy), has been shown to improve ...

Lung cancer patients had better survival if they got IV treatments before 3 p.m. They also had longer remission TUESDAY, Dec. 9, 2025 (HealthDay News) — Cancer survival might depend on what time of ...